Thomson Matthew Christopher sold $30K of BLND

Thomson Matthew Christopher (Head of Revenue) sold 15,041 shares of Blend Labs, Inc. (BLND) at $2.00 on 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Thomson Matthew Christopher
Published Aug 7, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BLND
Neutral
high confidence
Mentioned
$BLND
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLNDNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details (shares, price, total value) and confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation generally limits the incremental informational content versus non-plan sales.

03

What to watch

The article does not state whether this sale is part of a larger series, nor does it provide total insider ownership changes beyond the post-transaction share count.

Relevance 2/10Novelty 3/10Timing: today’s SEC Form 4 filing (filed 2026-08-07)

Background

The article is an SEC Form 4 insider transaction disclosure for Blend Labs, Inc. (BLND).

Company-level read

Ticker impact

$BLNDNeutralHigh confidence
Context

Blend Labs insider Form 4 shows Thomson Matthew Christopher sold 15,041 shares at $2.0040 on 2026-08-05 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived unless paired with other new company-specific news.

Evidence & confidence

The filing provides transaction size, price, and that it is pre-arranged via Rule 10b5-1, which typically reduces interpretability as a fresh bearish view.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with internal expectations of weaker near-term performance, so traders may watch for follow-on disclosures.

Key entities

  • Blend Labs, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Thomson Matthew Christopher

    Head of Revenue and reporting officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BLNDMed

Blend Announces Third Quarter 2026 Financial Results

Blend Labs, Inc. (BLND) filed an SEC Form 8-K — Results of Operations and Financial Condition. Blend Announces Third Quarter 2026 Financial Results November 5, 2026 SAN FRANCISCO -- Blend Labs, Inc. (NYSE: BLND), a leading digital banking platform, today announced its third quarter 2026 financial results. “We had our best sales quarter in more than three years,” said Nima

$BLNDMed

Blend Announces Second Quarter 2026 Financial Results

Blend Labs, Inc. (BLND) filed an SEC Form 8-K — Results of Operations and Financial Condition. Blend Announces Second Quarter 2026 Financial Results August 6, 2026 SAN FRANCISCO -- Blend Labs, Inc. (NYSE: BLND), a leading origination platform for digital banking solutions, today announced its second quarter 2026 financial results. "We delivered Q2 with revenue near the hig

$BLNDMed

British Land reports strong Q1 leasing momentum By Investing.com

British Land reported Q1 FY2027 leasing of 567,000 sq ft, completed at 4.8% above estimated rental value and 8.7% above prior passing rents. An extra 1.1m sq ft is under offer. Near-full occupancy was noted for retail parks and London Urban Logistics. Disposals totaled £83m at 3.2% net initial yield. FY2027 underlying EPS guidance of at least 30.5p was kept.